Search

Headquarters

Contact Us

  • (+01) 512 835 8026
  • 3300 Duval Road
    Austin, TX 78759
    USA
  • Mon to Fri - 8:50am to 5:00pm

Ready to order?

Great! Every order starts with a quote.

Get Started 

  • (+01) 512 835 8026
  • Email Us
Get a Quote Contact | FAQ's | Blog
Rules-Based Medicine Rules-Based Medicine

a Q<sup>2</sup> Solutions Company

Toggle menu

Skip to content
  • About Us

    • About RBM

      Rules-Based Medicine (RBM), a Q2 Solutions Company, is a CLIA certified, multiplexed immunoassay testing laboratory that solves complex drug development challenges with innovative biomarker services.

    • About RBM

      • About Us
      • Management
      • Quality Policy
      • Employment
      • Partners
      • Sales Team
      • Certifications

    • Newsroom

      • Press
      • Company Newsletters
      • Conferences
      • Abstracts + Papers
      • Sign Up for Our Newsletter
      • Blog

    • Data Quality

      • Overview
      • RBM Technology
  • Biomarker Solutions

    • Solutions

      • Overview
      • Assay Change Log

      CustomMAP

      If a smaller, more focused panel of analytes is required, we can build a Custom MAP to meet your needs.

      Learn More »

      TruCulture Spike

    • Multiplexed Immunoassays

      • Full Biomarker Menu
      • DiscoveryMAP® v. 4.0
      • ExplorerMAP™ v. 1.0
      • HumanMAP® v. 2.0
      • CardiovascularMAP® v. 3.0
      • AngiogenesisMAP® v. 1.0
      • InflammationMAP® v. 1.1
      • ImmunoMAP® v. 1.0
      • MetabolicMAP® v. 1.0
      • KidneyMAP®
      • CytokineMAP A
      • CytokineMAP B
      • SARS-CoV-2/COVID-19 Research
      • Cytokine Storm Testing for SARS-CoV-2/COVID-19 Research
    • TruCulture

      Whole Blood Collection and Culture System

      Learn More »
      Quanterix simoa

      Ultrasensitive immunoassays manufactured by RBM and based on Quanterix’s Simoa technology.

      Learn More »
  • Resources + Support

    • Resources

      • Bibliography
      • White Papers
      • Application Notes
      • Events
      • Webinars
      • Blog
      • COVID-19/SARS-CoV-2 Research Tools

    • Support

      • Client Services
      • Request a Biomarker
      • Speak to a Scientist
  • How to Order

    • Ordering Information

      • How to Order
      • Request a quote
      • Acceptable Samples
      • Frequently Asked Questions

    • Request Information

      • Contact Client Services
      • Request a Biomarker
      • Speak to a Scientist

    • Ready to Order?

      Great!

      Every order starts with a quote.

      Get Started

Category Archives: Press

3 Apr 2012

The Spinal Muscular Atrophy Foundation Announces a Biomarker Panel to Guide SMA Therapeutic Development

April 3, 2012
Desiree Klingler-Gaston
Press
NEW YORK, NY - April 3, 2012 - The Spinal Muscular Atrophy (SMA) Foundation announced today the launch of a biomarker assay panel for SMA using Myriad...
Read More
25 May 2011

RBM Reaches Milestone in Companion Diagnostic Program With Roche

May 25, 2011
Desiree Klingler-Gaston
Press
Milestone Demonstrates Effectiveness of RBM's Strategic Biomarker Services AUSTIN, Texas, May 25, 2011 /PRNewswire/ -- Rules-Based Medicine (RBM),...
Read More
17 May 2011

RBM Acquires Intellectual Property Assets of Satoris, Inc.

May 17, 2011
Desiree Klingler-Gaston
Press
Expansion of IP portfolio to support development and commercialization of novel tests for neurodegenerative diseases AUSTIN, Texas, May 17, 2011 /P...
Read More
12 May 2011

RBM& Institut Pasteur Partner to Boost Translational Research

May 12, 2011
Desiree Klingler-Gaston
Press
RBM's TruCulture® sample collection system will be an integral part of study AUSTIN, Texas, May 12, 2011 /PRNewswire/ -- Rules-Based Medicine, Inc....
Read More
28 Apr 2011

Myriad Genetics Announces Agreement to Acquire Rules-Based Medicine

April 28, 2011
huckster
Press
Acquisition Expands Myriad's Leadership Position in Companion Diagnostics SALT LAKE CITY and AUSTIN, Texas, April 27, 2011 (GLOBE NEWSWIRE) -- Myri...
Read More
4 Apr 2011

RBM’s OncologyMAP to Advance Cancer-Related Drug & Diagnostic Dev

April 4, 2011
Desiree Klingler-Gaston
Press
Panel of 101 quantitative biomarker tests selected in partnership with the National Cancer Institute AUSTIN, Texas, March 24, 2011 /PRNewswire/ --...
Read More
19 Jan 2011

SMA Foundation & RBM Collab on Biomarker Panels for Therapeutic Dev

January 19, 2011
Desiree Klingler-Gaston
Press
NEW YORK, NY AND AUSTIN, TX - January, 2011 - The Spinal Muscular Atrophy (SMA) Foundation and Rules-Based Medicine, Inc. (RBM) announced today that t...
Read More
1 2 3 4 5 6

Categories

  • Biomarkers (4)
  • Blog (134)
    • Autoimmune and Arthritis (10)
    • Cancer (28)
    • Cardiac (9)
    • Cytokines and Chemokines (20)
    • Diabetes (7)
    • Gastrointestinal (1)
    • Inflammation (42)
    • Neuroscience and Neurological (33)
    • News From the Lab (1)
    • Renal Function and Toxicity (8)
    • Technology- Multi-Analyte Profile (1)
    • TruCulture (2)
  • COVID-19 (1)
  • Press (37)
  • Utilized Rules-Based Medicine's Services (43)

ABOUT RBM

Overview
Management
Quality Policy
Employment
Partners
Sales Team
Certifications

A Q2 Solutions Company


Contact Us

Q2 Solutions, a wholly owned subsidiary and laboratory division of IQVIA, is a leading global clinical trial laboratory services organization providing comprehensive testing, project management, supply chain, biorepository and specimen management, and clinical trial sample and consent tracking solutions. Learn more at www.q2labsolutions.com.

MAPs

Full Biomarker Menu
DiscoveryMAP® v. 3.3
ExplorerMAP™ v. 1.0
HumanMAP® v. 2.0
CardiovascularMAP® v. 3.0
AngiogenesisMAP® v. 1.0
InflammationMAP® v. 1.0
ImmunoMAP® v. 1.0
NeuroMAP™ v. 1.0
MetabolicMAP® v. 1.0
KidneyMAP®
CytokineMAP A
CytokineMAP B

RESOURCES

Bibliography
White Papers
Events
Webinars
Blog

SUPPORT

Customer Support
Speak to a Scientist
Assay Change Log
Request a Biomarker
FAQs

SOLUTIONS

Results Processing
Assay Development
Quality Control
Project Management

SERVICES

Multiplexed Assay Services
Ultrasensitive Assays
TruCulture

  • Jobs
  • Terms of Use
  • Privacy Practice
  • Analytes Listing
Copyright © 2022 Rules-Based Medicine . All rights reserved. RBM does not sell your personal information